TL;DR
This paper introduces a novel Magnetic Resonance Imaging (MRI) method to quantify how efficiently lipid nanoparticles (LNPs) escape endosomes, a critical step for drug delivery. By incorporating iron oxide nanoparticles (IONPs) into LNPs, they leverage MRI's sensitivity to IONP dispersal as a marker for endosomal escape, enabling both in vitro and in vivo assessments.
What Problem Does This Paper Address?
Delivering therapeutic nucleic acids (like mRNA or siRNA) via lipid nanoparticles (LNPs) holds immense promise, as highlighted by the success of mRNA vaccines. However, a major hurdle is the "endosomal escape" – after cells engulf LNPs into internal compartments called endosomes, the LNPs must break out of these endosomes to release their cargo into the cell's cytoplasm where it can function. Current methods to measure this escape are often indirect, limited to in vitro studies, or lack the resolution for in vivo analysis. This gap makes it difficult to accurately assess LNP delivery platforms and optimize their design for better therapeutic outcomes.
Methods
The core of this work is the development of an MRI-based method for quantifying endosomal escape. The key steps are:
- IONP Synthesis and LNP Loading: Ultrasmall iron oxide nanoparticles (IONPs) were synthesized and then incorporated into lipid nanoparticles (LNPs) to create IONP-loaded LNPs (IO@LNPs). The IONPs act as MRI contrast agents.
- MRI Principle: The method relies on the change in the R₂ relaxation rate measured by MRI. When IONPs are clustered within intact IO@LNPs inside endosomes, they create a strong magnetic field inhomogeneity, leading to a higher R₂ value. As IO@LNPs escape the endosomes and the IONPs disperse into the cytoplasm, this magnetic inhomogeneity decreases, resulting in a lower R₂ value.
- In Vitro Studies:
- Phantom Tests: MRI scans of IONPs and IO@LNPs at varying concentrations were performed to establish baseline R₁ and R₂ values and their relationship with iron concentration.
- Cellular Uptake and Escape: Cells were incubated with IO@LNPs, and MRI was used to track changes in R₂ values over time (40-120 minutes) to determine the endosomal escape window. Chloroquine, a known endosomal escape enhancer, was used to validate the method.
- Electron Microscopy (TEM): Transmission electron microscopy was used to visualize the presence of IO@LNPs within endosomes and to correlate the number of endosomes with MRI R₂ signals.
- In Vivo Studies:
- Biodistribution: LNPs labeled with a fluorescent dye (DiR) were injected into mice to track their distribution using in vivo imaging.
- MRI in Mice: IO@LNPs were injected intramuscularly into mouse hindlimbs, and T₂-weighted MRI was used to monitor changes in R₂ signals at the injection site over time (0-3 hours).
- Bio-TEM: Muscle tissue samples from injected mice were analyzed using transmission electron microscopy to confirm the presence and dispersal of IONPs.
Datasets
Not explicitly discussed as "datasets" in the traditional machine learning sense. The study utilizes:
- In vitro cell culture models: 4T1 cells were used for in vitro experiments.
- Animal models: Balb/c mice were used for in vivo experiments.
- Physicochemical characterization data: FTIR, VSM, DLS, TEM, cryo-EM, and zeta potential measurements were performed on IONPs and IO@LNPs.
- MRI data: R₁ and R₂ relaxation rates were acquired from phantom tests, cell pellets, and in vivo tissue samples.
- Bio-TEM imaging data: Electron microscopy images of cells and tissue were analyzed.
Key Insights and Ideas
- IONPs as MRI Reporters for Endosomal Escape: The core idea is that the dispersal of IONPs from clustered LNP structures into the cytoplasm upon endosomal escape leads to a measurable decrease in the R₂ MRI signal. This provides a non-invasive, quantitative readout.
- R₂ Signal as the Primary Indicator: The study found that R₂ relaxation rates were much more sensitive to IONP dispersal than R₁ rates, making R₂ the key parameter for quantifying endosomal escape.
- Correlation Between R₂ and Endosome Occupancy: Electron microscopy confirmed a strong correlation between the R₂ value and the number of intracellular endosomes containing intact IO@LNPs, validating the MRI findings.
- In Vivo Applicability Demonstrated: The method successfully showed a decrease in R₂ signals in mouse muscle tissue after IO@LNP injection, indicating endosomal escape in a living organism.
- Distinguishing LNP Formulations: The technique could differentiate between LNP formulations with different helper lipids (DSPC vs. DOPE), showing that DOPE-containing LNPs exhibited faster endosomal escape, aligning with known properties.
Key Results
- In Vitro Endosomal Escape Index: An endosomal escape efficiency index of approximately 0.98 min⁻¹ was calculated for IO@LNPs in vitro.
- Chloroquine Enhancement: Treatment with chloroquine significantly reduced the initial R₂ values in cells, confirming its role in enhancing endosomal escape and validating the MRI method's sensitivity.
- DOPE vs. DSPC: IO@LNPs formulated with DOPE showed significantly higher endosomal escape efficiency compared to those with DSPC, particularly in the early stages (0-40 min).
- In Vivo R₂ Signal Decrease: In mice, a gradual increase in the R₂ signal (indicating IONP dispersal) was observed at the injection site over 3 hours, consistent with endosomal escape.
- TEM-MRI Correlation: A strong correlation (R² = 0.95) was found between the average frequency of endosomes containing IO@LNPs (from TEM) and the R₂ values measured by MRI.
Limitations and Future Work
- LNP Formulation Diversity: The study primarily focused on two LNP formulations (DSPC vs. DOPE). Future work should explore a wider range of LNP compositions to fully understand the relationship between formulation, endosomal escape, and therapeutic efficacy.
- Cell Line Specificity: While 4T1 cells were used, expanding to other cell lines would enhance the generalizability of the findings.
- Exocytosis and Biodegradation: The study acknowledges that exocytosis and biodegradation of IONPs could influence the observed decrease in endosomes and R₂ signals, especially at later time points. Future work should investigate these processes and potentially develop methods to account for them.
- Quantitative Index Comparison: The calculated in vitro endosomal escape efficiency index (≈1 min⁻¹) was noted as potentially higher than previously reported values. Further validation and comparison with other techniques (like Tomocube) are needed.
- Surrogate Marker: While IONPs serve as a good surrogate for tracking LNP behavior, directly tracking the therapeutic cargo (e.g., mRNA) in vivo with MRI would be the ultimate goal.
Summary updated